The telehealth leader reported a strong start to 2026 tonight, raising its first quarter revenue outlook to a range of $600M to $625M…
Adjusted EBITDA margins are holding at 9% as the company successfully scales its subscription model in a high inflation landscape…
The stock is seeing a “healthcare hedge” bump in after hours trading, as investors move toward predictable recurring revenue streams…
Management says the digital health platform is seeing record engagement, proving that personal wellness remains a priority even as gas prices surge…
While the physical world fights over tankers, the digital world is buying pills and potions.
Recurring revenue is the only real armor in a 3.3% inflation market.
Hims & Hers is proving that “convenience” is the ultimate war time luxury.